Celogics-Developing and producing highly reproducible iPSCs
Offering High-quality iPSC-derived Cell Products for Disease Modeling, Drug Discovery, and Drug Safety Screening
Located in the Greater Seattle Area, Celogics develops high-quality human-induced pluripotent stem cell products to advance drug discovery, safety screening, and therapeutic research.
Human iPSC-derived cells are rapidly becoming a vital tool in the drug development industry for the discovery, preclinical efficacy testing, and safety profiling of new drug candidates.